rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors

Summary

This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent chemotherapy , or combination with surgery for treatment of advanced oral and maxillofacial malignant tumors.

Timeline

Start

2009-06

Primary completion

2012-07

Completion

2012-07

Drugs

Indications